Published in Nature Medicine · View the paper (DOI)
Researchers at the University of Miami Miller School of Medicine identified distinct genomic events responsible for resistance to anti-BCMA and anti-GPRC5D immunotherapies in multiple myeloma. Mutations in the extracellular domain of BCMA impede T-cell binding without affecting protein expression or downstream signaling.
Coverage from 2 institutions